Phase II study of 3-hour infusion of paclitaxel in patients with previously untreated non-small cell lung cancer (NSCLC)

被引：0
|
作者：
Furuse, K
Naka, N
Ariyoshi, Y
Ikegami, H
Fukuoka, M
Yamakido, M
机构：
[1] NATL SANAT KINKI CENT HOSP,DEPT INTERNAL MED,OSAKA,JAPAN
[2] AICHI CANC CTR HOSP,DEPT CARDIOPULM DIS,AICHI,JAPAN
[3] OSAKA PREFECTURAL MED CTR ADULT DIS,DEPT INTERNAL MED 4,OSAKA,JAPAN
[4] HIROSHIMA UNIV,DEPT INTERNAL MED 2,HIROSHIMA,JAPAN
[5] OSAKA CITY GEN HOSP,DEPT PULM MED,OSAKA,JAPAN
来源：
EUROPEAN JOURNAL OF CANCER | 1995年 / 31A卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1072 / 1072
页数：1
相关论文
共 50 条
  • [41] Phase II study of everolimus plus erlotinib in previously treated patients with advanced non-small cell lung cancer (NSCLC)
    Soria, J. C.
    Bennouna, J.
    Leighl, N.
    Khuri, F.
    Traynor, A. M.
    Johnson, B.
    Kay, A.
    Blais, N.
    Jehl, V.
    Papadimitrakopoulou, V.
    EJC SUPPLEMENTS, 2009, 7 (02): : 558 - 559
  • [42] Phase II study of everolimus plus erlotinib in previously treated patients with advanced non-small cell lung cancer (NSCLC)
    Leighl, N. B.
    Soria, J.
    Bennouna, J.
    Blais, N.
    Traynor, A. M.
    Papadimitrakopoulou, V.
    Klimovsky, J.
    Jappe, A.
    Jehl, V.
    Johnson, B. E.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [43] Phase II study of dasatinib in non-small cell lung cancer (NSCLC)
    Johnson, F. M.
    Tang, X.
    Tran, H.
    Saigal, B.
    Erasmus, J.
    Kurie, J.
    Hwang, L.
    Oh, Y.
    Lippman, S.
    Stewart, D. J.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [44] Phase II study of mitonafide in non-small cell lung cancer (NSCLC)
    Casado, A
    Rosell, R
    GarciaGomez, R
    DiazRubio, E
    PerezManga, G
    Font, A
    Benavides, A
    Martin, M
    INVESTIGATIONAL NEW DRUGS, 1996, 14 (04) : 415 - 417
  • [45] A phase II study to determine if sensory neuropathy of nab-paclitaxel can be reduced by prolonging infusion in patients with non-small cell lung cancer (NSCLC)
    James, L. P.
    Kris, M. G.
    Heelan, R. T.
    Ng, K. K.
    Chia, G. H.
    Gomez, J. E.
    Krug, L. M.
    Moore, E.
    Hawkins, M. J.
    Rizvi, N. A.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [46] A PHASE II STUDY OF WEEKLY PACLITAXEL COMBINED WITH CARBOPLATIN VERSUS THE STANDARD EVERY 3-WEEKS PACLITAXEL AND CARBOPLATIN FOR ELDERLY PATIENTS WITH PREVIOUSLY UNTREATED ADVANCED NON-SMALL CELL LUNG CANCER
    El Shenshawy, H. M.
    Taema, S.
    ElZahaaf, E.
    Eldeen, D. Sharaf
    Elbeshbeshi, W.
    Fathy, A.
    JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (06) : S71 - S72
  • [47] Phase I study of irinotecan and gemcitabine in previously untreated, patients with advanced non-small cell lung cancer
    Takatani, Hiroshi
    Soda, Hiroshi
    Nakamura, Yoichi
    Kinoshita, Akitoshi
    Fukuda, Masaaki
    Nagashima, Seiji
    Fukuda, Minoru
    Soejima, Yoshifumi
    Nakano, Hirofumi
    Oka, Mikio
    Kohno, Shigeru
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2007, 37 (05) : 353 - 357
  • [48] Phase I study of vinorelbine and irinotecan in previously untreated patients with advanced non-small cell lung cancer
    Nanae Tomonaga
    Yoichi Nakamura
    Hiroshi Soda
    Seiji Nagashima
    Hirofumi Nakano
    Akitoshi Kinoshita
    Masaaki Fukuda
    Minoru Fukuda
    Hiroshi Takatani
    Yoshifumi Soejima
    Mikio Oka
    Shigeru Kohno
    Cancer Chemotherapy and Pharmacology, 2008, 62 : 43 - 49
  • [49] Phase I study of vinorelbine and irinotecan in previously untreated patients with advanced non-small cell lung cancer
    Tomonaga, Nanae
    Nakamura, Yoichi
    Soda, Hiroshi
    Nagashima, Seiji
    Nakano, Hirofumi
    Kinoshita, Akitoshi
    Fukuda, Masaaki
    Fukuda, Minoru
    Takatani, Hiroshi
    Soejima, Yoshifumi
    Oka, Mikio
    Kohno, Shigeru
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2008, 62 (01) : 43 - 49
  • [50] A phase I/II trial of paclitaxel, carboplatin, and gemcitabine in untreated patients with advanced non-small cell lung cancer
    Kelly, K
    Mikhaeel-Kamel, N
    Pan, ZX
    Murphy, J
    Prindiville, S
    Bunn, PA
    CLINICAL CANCER RESEARCH, 2000, 6 (09) : 3474 - 3479
12345